top of page

Dr. Jaganmohan Reddy received the award from the Honourable governor of Telangana Dr. Tamilisai Soundararajan in



Hyderabad: 28th February 2024: UR Advanced Therapeutics was one among the 75 startups selected from across the country to showcase their company in the strartup stadium in 21st edition of BioASIA2024 which was inaugurated on 27th February 2024 by Honourable Chief Minister of Telangana Mr. Revanth Reddy.


UR Advanced Therapeutics started their journey in 2020 based out of incubation centre ASPIRE-BioNEST, School of Life Sciences, University of Hyderabad. In a short span of time the company has grown many fold establishing its own integrated R&D facility with AI driven Bioinformatics, peptide synthesis, purification and analysis, BSL2 level facility of stem cell, organoid and Lenti and adenoviral systems. It has a dedicated team with a cumulative experience of 100 years with several PhDs and Masters degrees from academia and Industry. The company has several products ready for commercialization in the coming months. 


The main focus of the company is in Tissue engineering and is desigining extra cellular matrix to regenerate tissues. The company is developing patentable implants that regenerate the entire three layers of cornea using ones own stem cells that are present in the body. Presently, the available technologies that are in clinical trial stages uses the matrix from the human cadaveric tissues and thus will have rejections and risk of transmission of diseases. This novel technology first of its kind do not cause any rejections and since are synthesized in the lab can be scalable with consistent quality. This solves the scarcity of the available donor corneas that only one in 70 people have the access to globally.


“This recognition for developing the regenerative corneal implants is greatly appreciated by the UR Advanced therapeutics team “ said Dr. Jaganmohan Reddy, CEO, UR Advanced Therapeutics

留言


bottom of page